Tag Archives: Allosteric

Quantum Computing Targets Improved Human Aging and Longevity in new Agreement between Allosteric Bioscience and Polaris Quantum Biotech
February 3, 2022, Allosteric Bioscience, Inc., a company founded in 2021 to integrate Quantum Computing and Artificial Intelligence with various Biomedical sciences to create improved treatments for Aging, Longevity and Aging related diseases and Polaris Quantum Biotech, a company at the vanguard of Quantum Computing for drug discovery, have signed a collaboration agreement.  Together, the…
Read More